GlassScriptPhysician profile
Alexander C Allori
NPI 1316948532
$3,145.29
in general payments reported to CMS, 2019-2025
17 companies · $1,051 in 2025
The $1,051 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $279 · 2021: $51.31 · 2022: $91.13 · 2023: $957 · 2024: $278 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,217 · Entertainment: $70.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,216.74 |
| Entertainment | $70.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,022.41 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Musculoskeletal Transplant Foundation INC. | $272.38 | 2019-2025 | |
| Davol INC. | $245.49 | 2023-2024 | Phasix Mesh |
| Mentor Worldwide LLC | $181.31 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Innovation Technologies INC | $154.81 | 2025 | Irrisept |
| Access Pro Medical, LLC | $142.04 | 2025 | Matriderm |
| Axogen | $141.86 | 2020 | |
| Allergan, INC. | $137.18 | 2020 | |
| Biocomposites INC | $137.18 | 2025 | Stimulan |
| Dilon Technologies, INC. | $131.86 | 2023 | Hemoblast Bellows |
| Rti Surgical, INC | $125.94 | 2023 | |
| Baxter Healthcare | $106.75 | 2019 | |
| Medtronic, INC. | $91.13 | 2022 | |
| Ethicon US, LLC | $74.70 | 2019 | |
| Integra Lifesciences Corporation | $68.85 | 2023 | Durasorb Monofilament Mesh |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tei Medical INC. | $60.09 | 2019 | |
| Tela Bio, INC. | $51.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Allori listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.